about
Variations in erythropoiesis-stimulating agent administration in transfusion-dependent myelodysplastic syndromes impact response.Cost-effectiveness analysis of consolidation with brentuximab vedotin for high-risk Hodgkin lymphoma after autologous stem cell transplantation.Hypomethylating agent therapy use and survival in older patients with chronic myelomonocytic leukemia in the United States: A large population-based study.Do cancer survivors change their prescription drug use for financial reasons? Findings from a nationally representative sample in the United States.Long-term survival of older patients with MDS treated with HMA therapy without subsequent stem cell transplantation.Patterns of pain medication use associated with reported pain interference in older adults with and without cancerPatterns of Symptom Management Medication Receipt at End-of-Life Among Medicare Beneficiaries With Lung CancerEpidemiology of acute myeloid leukemia: Recent progress and enduring challengesHypomethylating agent (HMA) therapy use and survival in older adults with Refractory Anemia with Excess Blasts (RAEB) in the United States (USA): a large propensity score-matched population-based study†Underutilization of guideline-recommended supportive care among older adults with multiple myeloma in the United StatesTemporal patterns and predictors of receiving no active treatment among older patients with acute myeloid leukemia in the United States: A population-level analysisCost-Effectiveness of First-Line Ibrutinib versus Third-Line in Patients with Untreated Chronic Lymphocytic Leukemia
P50
Q35638905-8FF72671-45F1-498F-8EC4-C097CD94CC6FQ40149586-688CC868-801C-47F1-83C1-B3857CD620E7Q40157327-7AE1F7E4-3406-46E8-A469-B08C7D050DEFQ40327176-2F6A48C6-D18A-4EB5-BDFA-5789DCE588BCQ48092106-F7973790-79F1-4B1F-A3B1-AFF6174A24EAQ90865168-5566A5CA-EAB5-49D3-A535-DF94EB69BDA6Q91510909-3A8F016B-92F7-4BC0-94D5-79BCCFF6B265Q92123213-40CDFEEE-F4DD-4A9B-9AD3-455A56FFF840Q92262272-67B2BA78-C543-4EF0-ADA8-EEC3660B44A9Q92413813-4C32C06E-A553-4824-A805-DC2DAB46C9EEQ93097371-2667E4C5-7430-4540-B2DB-4096239E64BCQ96231841-291D87FC-6C42-4D5B-BF4E-AC43091F7F23
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Amy J Davidoff
@ast
Amy J Davidoff
@en
Amy J Davidoff
@es
Amy J Davidoff
@nl
type
label
Amy J Davidoff
@ast
Amy J Davidoff
@en
Amy J Davidoff
@es
Amy J Davidoff
@nl
prefLabel
Amy J Davidoff
@ast
Amy J Davidoff
@en
Amy J Davidoff
@es
Amy J Davidoff
@nl
P108
P106
P108
P21
P31
P496
0000-0001-8141-9249